Key stakeholders' stock returns and the affordable care act
Journal of Insurance Regulation · 2016
DOI: 10.52227/23498.2016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Insurance Regulation, 2016. Verfasst von Cassandra Cole und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The federal Affordable Care Act (ACA) is the most influential and sweeping health care reform of our generation. Within the ACA legislation, there are a number of key stakeholder industries that are affected by provisions in the law: health care providers, health insurance companies, medical/biotechnology companies and pharmaceutical companies. We investigate the effect of the passage of the ACA on the capital market response to the key stakeholder industries during the time period surrounding the date the final version of the bill was signed into law (March 23, 2010) and the date the law was upheld in the Supreme Court (June 28, 2012). These dates are particularly important as they convey new information to the market regarding the evidence the ACA would become law. Overall, we find that the passage of the ACA has a negative effect on health insurance companies, medical device companies, and companies that operate simultaneously in the health care and insurance industry, while having a positive influence on firms in the health care industry.
Zitieren
APA
Cole, C., Blau, B., Daines, B., Karl, J. B., & Wade, C. (2016). Key stakeholders' stock returns and the affordable care act. Journal of Insurance Regulation. https://doi.org/10.52227/23498.2016
Vancouver
Cole C, Blau B, Daines B, Karl JB, Wade C. Key stakeholders' stock returns and the affordable care act. Journal of Insurance Regulation. 2016. doi:10.52227/23498.2016
BibTeX
@article{Cole2016,
author = {Cole, Cassandra and Blau, Benjamin and Daines, Bryan and Karl, J. Bradley and Wade, Chip},
title = {Key stakeholders' stock returns and the affordable care act},
journal = {Journal of Insurance Regulation},
year = {2016},
doi = {10.52227/23498.2016}
}
EUVIMED